 Released: Oct 29, 2007
 Expires: Oct 31, 2009
 Type: PDF
Social and clinical advances in the management of human immunodeficiency virus (HIV) infection and the acquired immune deficiency syndrome (AIDS) continue to occur across the globe. Significant accomplishments include reductions in HIV-associated morbidity and mortality, introduction of less complex medications and dosing regimens, more thorough understandings of the processes...
|
- CME Credits/Hours: 2.00
- CPE Credits/Hours: 2.40
- Cost: $9.95
-
System Requirements:
|
 Released: Jun 11, 2008
 Expires: Jun 10, 2009
 Type: PDF
Rheumatoid arthritis (RA) currently afflicts 1.3 million American adults. A progressive disease of the joints with a recognized autoimmune component, RA causes eventual loss of joint structure and function. The disease is also associated with serious extraarticular and comorbid disease, evidenced by studies identifying a 10-15 year shorter lifespan for patients with RA. RA...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10 infections,...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10 infections,...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC)...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) remain one of the leading causes of death in the United States (US). As of December 2004, an estimated 944,306 persons have received a diagnosis of AIDS and of these, 529,113 have died. Since 1994, the annual number of HIV cases among blacks and other racial/ethnic minority...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 29, 2008
 Expires: Feb 28, 2009
 Type: Audio
STDs are common, costly, and preventable. Worldwide, an estimated 333 million cases of curable STDs occur annually. In 1995, STDs were the most common reportable diseases in the United States. They accounted for 87 percent of the top 10 infections most frequently reported to the Centers for Disease Control and Prevention (CDC) from State health departments. Of the top 10 infections,...
|
- CME Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- Credits/Hours:
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- CME Credits/Hours: 0.50
- CPE Credits/Hours: 0.50
- CNE Credits/Hours: 0.50
- Cost: Free
-
System Requirements:
|
 Released: Feb 19, 2008
 Expires: Feb 19, 2009
 Type: Video
Biologic agents that block TNF have proven highly effective in improving the signs and symptoms of rheumatoid arthritis (RA), preventing the progression of joint damage, and improving functional status and quality of life. The introduction of TNF inhibitors has helped elevate the goals of treating RA, such that low disease activity or even remission are commonly considered...
|
- Credits/Hours:
- Cost: Free
-
System Requirements:
|
 Released: Feb 15, 2008
 Expires: Feb 14, 2009
 Type: PDF
Rheumatology Highlights, a CME-accredited educational program, presents a carefully constructed report from a major international conference and is developed to equip readers with practical knowledge of the area under discussion. This newsletter is commissioned to support particular educational themes identified by the Editor-in-Chief, Editorial team and readers. This issue...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Feb 4, 2008
 Expires: Feb 4, 2009
 Type: Video
Kentucky All Schedule Prescription Electronic Reporting (KASPER) is Kentucky’s Prescription Monitoring Program (PMP). KASPER catalogs most of the Schedule II – V controlled substance prescriptions written and dispensed within the state and is used by health care professionals to help address the issue of controlled pharmaceutical substance abuse. We have...
|
- CME Credits/Hours: 1.25
- CPE Credits/Hours: 1.25
- CPE-T Credits/Hours: 1.25
- Cost: Free
-
System Requirements:
|
 Released: Nov 19, 2007
 Expires: Nov 19, 2008
 Type: PDF
The trend to minimize the use of calcineurin inhibitors (CNIs) and corticosteroids (CSs) has contributed to an increase in the use of antibody induction therapy in kidney and liver transplantation. Significant comorbid conditions associated with historical maintenance immunosuppressive regimens consisting of CNIs and CSs have resulted in a paradigm shift in clinical practice....
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.20
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Oct 16, 2007
 Expires: Oct 16, 2008
 Type: Video
The majority of hospitalized patients are at risk for venous thromboembolism (VTE), which is comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE). Medically ill patients—for example, those with congestive heart failure, respiratory illness, or infectious or inflammatory disease—are at an increased risk of developing VTE. VTE is the most common...
|
- CME Credits/Hours: 1.00
- CPE Credits/Hours: 1.00
- CNE Credits/Hours: 1.00
- Cost: Free
-
System Requirements:
|
 Released: Oct 16, 2007
 Expires: Oct 16, 2008
 Type: Video
The majority of hospitalized patients are at risk for venous thromboembolism (VTE), which is comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE). Medically ill patients—for example, those with congestive heart failure, respiratory illness, or infectious or inflammatory disease—are at an increased risk of developing VTE. VTE is the most common...
|
- CME Credits/Hours: 1.75
- CPE Credits/Hours: 1.75
- CNE Credits/Hours: 1.75
- Cost: Free
-
System Requirements:
|
|